Form 4: Director Janet Vergis Receives RSU Grant at Dentsply Sirona

Director Janet S. Vergis was granted 22,822 restricted stock units in Dentsply Sirona Inc. as part of an equity compensation award.

Summary

• Director Janet S. Vergis acquired 22,822 restricted stock units (RSUs) in Dentsply Sirona Inc. (XRAY).
• The transaction occurred on June 3, 2026.
• The RSUs were granted at a price of $0, representing an equity award.
• Following this transaction, the reporting person's total beneficial ownership is 67,324 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation.

Positives

• The grant aligns the director's interests with long-term shareholder value through equity ownership.

Negatives

• None identified; this is a standard equity compensation disclosure.

Risks

• The value of the RSU grant is subject to future fluctuations in the company's share price.

Future Outlook

The RSUs vest in full one year from the date of grant, on June 3, 2027.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practices designed to ensure alignment between leadership and shareholders in the dental technology sector.

Comparison to Industry Standards

• The use of RSUs as a component of director compensation is consistent with standard practices among S&P 500 and mid-cap healthcare companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity compensation event.

Next Steps

• Vesting of the 22,822 RSUs on June 3, 2027.

Key Dates

Keywords

Dentsply Sirona, XRAY, Form 4, Insider Trading, Restricted Stock Units, Director Compensation